Julia Meyer

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Chronic Kidney Disease

Ejection Fraction

Acute Lymphoblastic Leukemia

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, David C Hall, Scott C Kogan, Julia Meyer, Steven D Rhodes, Sarah K Tasian, Xiaoling Xuei, Kevin Shannon, Mignon L Loh, Elizabeth Fox, Brenda J Weigel
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group. Cancer discovery (2024)